mark-smith.JPG

Marty Felsenthal

Managing partner

Marty has worked exclusively with innovative, disruptive, and rapidly growing healthcare software and services companies for more than 20 years.  He was previously a partner at two leading venture and growth capital firms focused on this sector -- Salix Ventures and HLM Venture Partners - and also worked with Madison Dearborn Partners earlier in his career.  He has led investments in and/or served on the Boards of Directors of companies such as TelaDoc (NYSE:  TDOC); Change Healthcare (acquired by Emdeon); Aperio (acquired by Leica Biosystems); Titan Health (acquired by United Surgical Partners); US Renal Care (acquired by Leonard Green);  Payerpath (acquired by Misys/Allscripts); Vantage Oncology (acquired by McKesson); NovoLogix (acquired by CVS Health); VeriCare (acquired by MedOptions); OnShift; and ClearData Networks.  Marty received his AB from Princeton University and his MBA from the Stanford University Graduate School of Business.


Bruce Crosby

Managing partner

Bruce has spent 25 years as a healthcare executive, entrepreneur, and venture and growth stage investor. He has helped build and invested in a number of high growth, successful healthcare software and services companies with revenues ranging from $10 million to $700 million. Bruce's executive roles have all been focused on the growth of these businesses and included senior responsibility for Business Development, Corporate Development, Product Development, Strategy, Sales, and Marketing. He has served customers in many of the largest sectors within healthcare services. 

Bruce's executive roles have been with Compassus, the nation's 3rd largest hospice and palliative care company; Healthways (NASDAQ: HWAY), the nation's largest independent disease and population health management company and largest Medicare Advantage consumer services benefit provider; and The Advisory Board Company (NASDAQ: ABCO), one of the nation's largest health system best-practice research and software businesses. At JPMorgan Partners, Bruce led investments in Accordant Health Services (acquired by AdvancePCS) and National Surgical Care (acquired by Amsurg), and played a key role in the buyout of the initial hospitals to form IASIS Healthcare (acquired by TPG Capital). At Healthways, he drove investments in D2Hawkeye (acquired by Verisk Analytics) and iTriage (acquired by Aetna).  Bruce received his AB from Princeton University and his MBA from the Wharton School at The University of Pennsylvania.


Saurabh Bhansali

Partner

Saurabh has spent his career working with innovative healthcare services and software companies.  Most recently, Saurabh helped build and lead investments for Humana Health Ventures, the venture capital arm at one of the nation’s leading healthcare companies and second largest Medicare Advantage insurer. At Humana (NYSE: HUM), Saurabh led an investment in Aspire Health, an important and leading provider of palliative and end-of-life care management, and was also actively involved with investments in Omada Health and Livongo Health, both first-movers in digital health management in the areas of pre-diabetes and Type II diabetes, respectively.  In addition to his formal investing responsibilities, he was also a key member in driving discovery and innovation efforts across Humana’s enterprise, developed best practices to drive the right innovative companies and themes throughout the company, and was recognized as a Rising Star by the Global Corporate Venturing organization in 2017.  Prior to Humana, Saurabh was on the investing team at HLM Venture Partners, where he was involved in investments in Binary Fountain, ClearDATA Networks, and AbleTo and served as a Board Observer at Vericare Management (acquired by MedOptions) and Imagine Health. He also held roles at Ferrer Freeman & Co. as part of the investing team, at Bank of America Merrill Lynch as an investment banker, and at Pfizer as part of the mergers, acquisitions and licensing team.  Saurabh received his BA from Northwestern University and his MBA from The Wharton School at the University of Pennsylvania.


Julie Foster.jpg

JULIE FOSTER

administrator

Julie is the administrator for Health Velocity Capital and is responsible for making our trains run on time.  She has been working in the venture capital industry since 1999 at firms including Salix Ventures, De Novo Ventures, and HLM Venture Partners.


David Felsenthal

Founding Advisory Board Member

David Felsenthal serves as president of The Advisory Board Company (NASDAQ:  ABCO) a global research, technology, and consulting firm that serves over 4,100 leading organizations across health care and higher education.  Having first joined the firm in 1992, he previously served as The Advisory Board Company’s chief operating officer and chief financial officer and has also held roles in both new product development and research.  He formerly served as director of business development and special assistant to the CEO/CFO at Vivra Specialty Partners, a private health care services and technology firm.


Doug Ghertner

Founding Advisory Board Member

Doug Ghertner is the former Chief Sales Officer and President, Engagement Solutions, of Emdeon (now Change Healthcare).  Previously, he was CEO of Change Healthcare prior to its acquisition by Emdeon.  Change Healthcare was a leading provider of member engagement and cost transparency solutions sold to health plans and large self-insured employers.  During his tenure, Change Healthcare increased the number of individuals who received its services from 20,000 to more than 15 million.  Prior to joining Change Healthcare as CEO, Doug served in a variety of leadership roles with CVS, including SVP of Client Solutions.


Ben Leedle

Founding Advisory Board Member

Ben Leedle served as CEO of Healthways (NASDAQ:  HWAY) from 2003 until 2015.  During his tenure as CEO, Healthways increased revenue from $165 million to $770 million and became the leading independent disease management, population health management, consumer engagement, and senior-focused consumer services company in healthcare.  Ben joined Healthways in 1985 initially supporting early models for advancing population health for people with diabetes. Over his 30-year career with the company, he rose in the organization as a leader and manager of business development, product management, and operations – serving as the company’s Chief Operating Officer - before being elected President & Chief Executive Officer, and Board Director of Healthways in 2003.


Kent_Marquart_Print2.jpg

Kent Marquardt

Founding Advisory Board Member

Kent is the former Executive Vice President and Chief Financial Officer of Premera Blue Cross, where he was responsible for finance, corporate informatics, healthcare economics, innovation, and strategic investments.  As part of these efforts, he identified and sponsored a number of important and successful healthcare innovators and played a key role as an early customer at companies such as Landmark Health, Teladoc, and MOBE.  He previously served as a partner with KPMG Peat Marwick, as Chief Financial Officer for PriMed Management Consulting (Hill Physician Management Company), as CEO of American Dental Specialists, and Chief Operating Officer and Chief Financial Officer of the western operations for MedPartners, the nation’s then largest publicly held physician practice management company.  He currently serves as an independent board of director at Landmark Health and Cardinal Analytics and as an advisory for BookMD.


Scott Powder

Founding Advisory Board Member

Scott Powder has been a strategic thought leader at Advocate Health Care, one of the leading integrated health care delivery systems in the country, for over 23 years. In his current role as Senior Vice President and Chief Strategy Officer, he oversees Advocate’s long range strategic planning and business development activities, including mergers, acquisitions, and strategic partnerships. He has held a number of business development and strategy positions during his tenure.

Scott previously served as Board Chair for the Business Solutions Division of the Illinois Hospital Association and currently serves on the Board of RML Specialty Hospital, a leading long-term acute care hospital in Chicago.  He has an MBA from the Kellogg Graduate School of Management at Northwestern University and a BA in International Relations from Michigan State University.


Mark Smith, M.d.

Founding Advisory Board Member

Mark Smith, MD serves as Co-chair of the Health Care Payment Learning & Action Network’s Guiding Committee. He is Visiting Professor, University of California at Berkeley, and Clinical Professor of Medicine, University of California at San Francisco.  He was the Founding President and former Chief Executive Officer of the California HealthCare Foundation (CHCF).  Previously, Mark was Executive Vice President at the Henry J. Kaiser Family Foundation where he oversaw programs in HIV, reproductive health, and the health care marketplace. Prior to that, he was a faculty member at the Johns Hopkins Schools of Medicine and of Public Health. Dr. Smith was elected a member of the Institute of Medicine (IOM) in 2001 and chaired the IOM’s Committee on the Learning Healthcare System, which produced the 2012 report, Best Care at Lower Cost.  He has served on the board of the National Business Group on Health, the performance measurement committee of the National Committee for Quality Assurance, and the editorial board of the Annals of Internal Medicine.


lew trowbridge

FOUNDING ADVISORY BOARD MEMBER

Lew is the former President and COO of Blue Cross Blue Shield of Nebraska, where he also served as Chief Financial Officer and Treasurer. Prior to joining Blue Cross Blue Shield of Nebraska, Lew was the CEO of World Marketing, Inc., a private equity roll-up in the newspaper and direct marketing arena, and the CEO of The SilverStone Group, Inc., a large regional insurance brokerage and human resource/actuarial consulting firm. He was also a Managing Partner at KPMG. Lew currently serves as a board member of Think Whole Person Primary Care LLC, a first of its kind, integrated care delivery enterprise with 46,000 patients and 24 independent primary care physicians; of a $900 million regional bank based in Omaha; and is a trustee of the W. David Scott Foundation. Lew was previously on the boards of TriWest Health Alliance, which administered the Tricare contract for the western 21 states; HTH (now GeoBlue), an insurance company offering international health insurance products for ex-patriots, students and other overseas travelers; Nebraska Medical Center; and the Peter Kiewit Institute. Lew was also the co-founder of the Blue Investment Collaborative, a coalition of 10 like-minded Blue plans who meet regularly to discuss collaborative private equity investment opportunities.


Frank Williams

Founding Advisory Board Member

Frank Williams serves as Chief Executive Officer of Evolent Health (NYSE:  EVH). Evolent works with leading health systems to achieve superior clinical and financial results through value-based care transformation. The company employs over 1,000 professionals across its corporate and client locations in 25 markets nationwide. Backed by capital, asset and intellectual property contributions from UPMC Health Plan and The Advisory Board Company, Evolent completed an initial public offering in June of 2015. Prior to Evolent, Frank served as Chief Executive Officer and Chairman of The Advisory Board Company, a global research, technology, and consulting firm that serves over 4,100 leading organizations across health care and higher education. During Frank’s tenure as both its Chairman and CEO, The Advisory Board completed an initial public offering and grew to $450M+ in annual revenues with over 2,500 employees and $2B+ in market capitalization. Frank previously served as the President of MedAmerica OnCall, the President of Vivra Orthopedics and as a Consultant for Bain & Co.